The Global Photodynamic Therapy Market Size valued for USD 5 Billion in 2021 and is anticipated to reach USD 18.1 Billion by 2030 with a CAGR of 15.5% from 2022 to 2030.

With the help of particular medications, commonly referred to as photosensitizing agents, and light, photodynamic therapy (PDT) kills cancer cells. The medications only function after being "switched on" or activated by specific types of light. PDT is also also referred to as phototherapy, photoradiation therapy, or photochemotherapy.

Your doctor administers a photosensitizer to you throughout the course of treatment. This medication may be administered orally (as a tablet), intravenously (via a vein), or topically (by applying it directly to the skin), depending on where the target location is located in your body. In order to make cancer cells and other sick cells more sensitive to light, photosensitizing medicines concentrate in those cells.

Photodynamic Therapy Market Dynamics

The market for photodynamic therapy is expanding quickly, largely as a result of the rising incidence of skin conditions worldwide. According to estimates from the International Agency for Research on Cancer, 1 in 5 people will develop cancer at some point in their lives, and 1 in 8 men and 1 in 11 women will pass away from the condition. By the time they reach the age of 70, 1 in 5 Americans will have skin cancer, according to the Skin Cancer Foundation. Cancer incidence is rising as a result of people being exposed to more dangerous UV radiation.

The fourth most prevalent condition worldwide, skin infections are fairly widespread. Particularly in poorer nations, these are one of the main causes of non-fatal disability. In order to lessen the financial burden of skin problems in low-resource settings, a treatment plan must be developed. One of the most common skin conditions in the U.S., acne affects about 50 million people annually. More than 15% of all adult females are affected, which is a sign of its increased incidence among women.

However, several negative effects of photodynamic therapy, such as increased susceptibility to ultraviolet light from the sun and strong lights, could limit market revenue growth throughout the projection period. Reactions, which typically entail a burning/tingling sensation and redness, can manifest on skin where photosensitizing chemicals have been administered. Additionally, patients must exercise caution for a set amount of time and should avoid exposing treated areas to light after treatment, notably the face and scalp.

Photodynamic Therapy Market Insights

The photodynamic therapy market is divided into product, application, and end-use. Based on the product, the market is divided into drugs and devices. Drugs segment is further sub-segmented into porphyrin derivative (PD), aminolevulinic acid (ALA), chlorines, and others. Devices segment is further divided into disposable fiber optic light delivery devices (DFOLDD), and diode lasers. The photosensitizer drug category led the market in 2021 as a result of its use in ophthalmology, cancer, and dermatology. In order to damage the cell structures of ill mammalian cells and ultimately cause cell death, photosensitizer medications can be triggered by light.

The application segment is further divided into cancer (basal cell carcinoma, non-small cell lung cancer, head & neck cancer, and others), acne, actinic keratosis (AK), psoriasis, and others. Due to the global incidence and frequency of cancer cases, the Cancer sector held the largest market share in 2020. Furthermore, the end-use segment is further categorized into hospitals, cosmetics & dermatology clinics, and cancer treatment centers, and others. The segment of cosmetic and dermatology clinics held the largest market share in 2020, followed by cancer treatment facilities.

Global Photodynamic Therapy Market Geographical Competition

The North America, Europe, Latin America, Asia-Pacific, and the Middle East & Africa regions make up the five geographical segments of the global Photodynamic Therapy market. Due to the presence of major players in the U.S., the rise in demand for novel biologics for the treatment of cancer, the high rate of utilization of photodynamic therapy, and new product debuts by market players, North America is anticipated to hold the largest share of the global market for photodynamic therapy during the forecast period. The photodynamic therapy market in North America is being driven by an increase in product approvals by the FDA, a surge in the use of photodynamic therapy for the treatment and management of actinic keratosis, and an increase in the number of cosmetologists offering photodynamic therapy.

Global Photodynamic Therapy Industry Segment Analysis

Photodynamic Therapy Market By Product

·         Drugs

o   Porphyrin Derivative (PD)

o   Aminolevulinic Acid (ALA)

o   Chlorines

o   Others

·         Devices

o   Disposable Fiber Optic Light Delivery Devices (DFOLDD)

o   Diode Lasers

Photodynamic Therapy Market By Application

·         Cancer

o   Basal Cell Carcinoma

o   Non-small Cell Lung Cancer

o   Head & Neck Cancer

o   Others

·         Actinic Keratosis (AK)

·         Psoriasis

·         Acne

·         Others

·          

Photodynamic Therapy Market By End-Use

·         Hospitals

·         Cosmetics & Dermatology Clinics

·         Cancer Treatment Centers

·         Others

Photodynamic Therapy Market Leading Companies

This section of the study honors the market's top vendors Theralase Technologies Inc., Lumibird, Quest PharmaTech Inc., Modulight, Inc., Galderma Laboratories L.P., Biofrontera AG, Sun Pharmaceutical Industries Ltd., and SUS Advancing Technology Co., Ltd.

Photodynamic Therapy Market Regions